TOT BIOPHARM International Company Limited (1875.HK)

HKD 1.65

(0.0%)

Net Income Summary of TOT BIOPHARM International Company Limited

TOT BIOPHARM International Company Limited's latest annual net income in 2023 was -37.75 Million CNY , up 24.36% from previous year.
TOT BIOPHARM International Company Limited's latest quarterly net income in 2024 Q2 was 31.55 Million CNY , down 0.0% from previous quarter.
TOT BIOPHARM International Company Limited reported an annual net income of -49.91 Million CNY in 2022, up 80.89% from previous year.
TOT BIOPHARM International Company Limited reported an annual net income of -261.21 Million CNY in 2021, up 9.46% from previous year.
TOT BIOPHARM International Company Limited reported a quarterly net income of -37.75 Million CNY for 2023 FY, up 24.36% from previous quarter.
TOT BIOPHARM International Company Limited reported a quarterly net income of -22.59 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of TOT BIOPHARM International Company Limited (2023 - 2017)

Historical Annual Net Income of TOT BIOPHARM International Company Limited (2023 - 2017)

Year	Net Income	Net Income Growth
2023	-37.75 Million CNY	24.36%
2022	-49.91 Million CNY	80.89%
2021	-261.21 Million CNY	9.46%
2020	-288.49 Million CNY	12.89%
2019	-331.17 Million CNY	-23.45%
2018	-268.26 Million CNY	-80.42%
2017	-148.68 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q2	31.55 Million CNY	0.0%
2023 FY	-37.75 Million CNY	24.36%
2023 Q4	-22.59 Million CNY	0.0%
2023 Q2	-15.16 Million CNY	0.0%
2022 FY	-49.91 Million CNY	80.89%
2022 Q4	-34.19 Million CNY	0.0%
2022 Q2	-15.72 Million CNY	0.0%
2021 Q2	-115 Million CNY	0.0%
2021 Q4	-146.21 Million CNY	0.0%
2021 FY	-261.21 Million CNY	9.46%
2020 Q4	-159.31 Million CNY	0.0%
2020 FY	-288.49 Million CNY	12.89%
2020 Q2	-129.18 Million CNY	0.0%
2019 Q2	-115.68 Million CNY	0.0%
2019 Q4	-183.61 Million CNY	0.0%
2019 FY	-331.17 Million CNY	-23.45%
2018 Q2	-67.06 Million CNY	0.0%
2018 FY	-268.26 Million CNY	-80.42%
2018 Q1	-67.06 Million CNY	0.0%
2018 Q4	-74.82 Million CNY	0.0%
2017 Q2	-37.17 Million CNY	0.0%
2017 Q4	-67.06 Million CNY	0.0%
2017 Q1	-37.17 Million CNY	0.0%
2017 FY	-148.68 Million CNY	0.0%
2016 Q4	-37.17 Million CNY	0.0%

Peer Net Income Comparison of TOT BIOPHARM International Company Limited

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	153.272%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	318.881%